Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300075752Phase 4Not yet recruiting
Phase 4, randomised trial in gallbladder disease and biliary disease comparing Esketamine arm, Oxycodone arm and Sufentanil arm (3 arms). Primary endpoint: Pain conditions (incision pain, visceral pain, shoulder referred pain). Planned start Sep 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300075752.